A-10 Amino Matrix Blue Raz
A-10 Amino Matrix Blue Raz is an amino acid and electrolyte blend, categorized as 'Other Combinations,' containing 9 ingredients. This product received an N+ Score of 53, earning an 'F' grade, indicating a below-average quality assessment. While it includes Vitamin C at a clinical dose of 100mg, several key electrolytes such as Potassium (105mg), Vitamin D3 (250IU), and Chloride (327mg) are underdosed according to our analysis. The formula completeness scored 33% and ingredient adequacy 13%, suggesting a limited and potentially insufficient blend of ingredients for comprehensive support. This product may be considered by individuals looking for a basic amino acid blend with some added electrolytes, but should note the underdosed components.
About This Product
A-10 Amino Matrix Blue Raz by Evlution Nutrition is a protein supplement containing 9 active ingredients. It has earned an N+ Score of 53/100 (Grade F).
Notable clinical-dose ingredients include Vitamin C.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +1 ingredient(s) at clinical dose levels
Weaknesses
- −Several ingredients below clinically effective doses
- −Missing several expected ingredients for its category
Ingredient Analysis (9 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Vitamin C | 100.000 mg | Adequate |
| Sodium | 108.000 mg | N/A |
| Potassium | 105.000 mg | Under |
| Vitamin D3 | 250.000 IU | Under |
| Chloride | 327.000 mg | Under |
| 4:1:1 BCAA Matrix | 3000.000 mg | N/A |
| Muscle Performance Ammo | 3075.000 mg | N/A |
| Recovery Boost | 3000.000 mg | N/A |
| Neuro Support | 935.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.